Please assess the completion status of the following clinical trial:

Trial Title: Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Pathologically confirmed adenocarcinoma of the pancreas or a serum CA19-9 level higher than normal limits and an pancreas cancer-compatible radiological features in one or more in CT/MRI/PET scans~* Unresectable disease base on institutional standard criteria of unresectability or recurrent disease following radical surgery. There is no evidence of metastatic disease in the major viscera and no peritoneal seeding~* Patients with biliary or gastroduodenal obstruction must have drainage prior to starting chemoradiation~* All malignant disease must be encompassable within a single irradiation field (15x15cm maximum)~* All patients must have radiographically assessable disease~* No previous irradiation to the planned field~* Age of ≥ 18 years~* Performance status of 0 to 2 on the Eastern Cooperative Oncology Group (ECOG) score~* Required Entry Labortory Parameters:~  * WBC count ≥ 2,000/mm3~ * hemoglobin level ≥ 7.5 g/dL~ * platelet count ≥ 100,000/mm3~ * total bilirubin ≤ 2.0 mg/dL (Patients with elevated bilirubin due to obstruction should be stented and their bilirubin should be decreased ≤ 2.0 mg/dL prior to study entry)~ * creatinine ≤ 3.0 mg/dL~* Oral intake (including J-tube feeding) of ≥ 1,500 calories/day should be maintained.~Exclusion Criteria:~* There is evidence of metastasis in the major viscera or peritoneal seeding.~* Age of \< 18 years~* Previous history of RT adjacent to planned field~* Poor performance status of 3 to 4 on the Eastern Cooperative Oncology Group (ECOG) score~* Pregnant or breast feeding status~* Previous history uncontrolled other malignancies within 2 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).